HCTI earnings analysis
What we found in HCTI's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The supplied 10-Q extract is limited to market-risk, controls, legal-proceeding, and other-information sections and does not include current-quarter revenue, margins, EPS, balance-sheet data, cash flow, or segment results. Controls were deemed effective as of June 30, 2026, and management reported no material control changes or unusual litigation. No material risk-factor changes or quantitative financial guidance were disclosed.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Disclosure controls deemed effective
- Management concluded that disclosure controls and procedures were effective as of June 30, 2026, under the supervision of the COO and CFO.
- No material control changes
- The company reported no changes during the quarter ended June 30, 2026, that materially affected or were reasonably likely to materially affect internal control over financial reporting.
- No material unusual litigation
- The filing states that the company is not currently involved in any claim outside the ordinary course that is material to financial condition or results of operations.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- No updated risk-factor detail
- Item 1A states that there were no material changes to the risk factors disclosed in the Form 10-K filed April 16, 2026; therefore, the filing provides no new quantified risk-factor exposure.
- Limited market-risk disclosure
- Under Item 3, the company states that it had no investments and did not use derivative financial instruments to manage interest-rate risk, limiting disclosure of any related market-risk exposure.
- Current-period financial data unavailable
- The filing does not provide the current-quarter financial statements, balance-sheet amounts, cash-flow figures, or segment results in the supplied text, preventing assessment of liquidity and operating trends for the quarter ended June 30, 2026.
What they said about what is next.
The provided 10-Q text contains no quantitative revenue or EPS outlook and does not state whether prior guidance was raised, maintained, lowered, or withdrawn.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 14, 2026
- Healthcare Triangle, Inc. (HCTI) reported significantly improved financials in Q4 2025 with revenues of $9.86 million, marking a 166% increase compared to $3.70 million in the same quarter of the previous year. However,…
- 10-K · April 15, 2026
- Healthcare Triangle (HCTI) positions itself as a cloud- and data-focused healthcare IT vendor with proprietary platforms (CloudEz, DataEz, Readabl.AI, Ziloy, Ezovion) and partnerships with AWS, Google Cloud and…
- 10-Q · November 13, 2025
- Healthcare Triangle reported Q3 2025 revenue of $3,489,000, up from $2,413,000 in Q3 2024, but the company widened operating loss and reported a net loss of $1,906,000 (EPS -$0.42). Liquidity improved via equity…
- 10-K · March 31, 2025
- Healthcare Triangle positions itself as a healthcare IT and cloud/data science services provider emphasizing proprietary platforms CloudEz, DataEz and Readabl.AI (all “commercially available”) and partnerships with AWS,…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing HCTI makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever